Bausch + Lomb Balance Sheet Health
Financial Health criteria checks 2/6
Bausch + Lomb has a total shareholder equity of $6.7B and total debt of $4.6B, which brings its debt-to-equity ratio to 69.5%. Its total assets and total liabilities are $13.5B and $6.9B respectively. Bausch + Lomb's EBIT is $189.0M making its interest coverage ratio 0.5. It has cash and short-term investments of $329.0M.
Key information
69.5%
Debt to equity ratio
US$4.63b
Debt
| Interest coverage ratio | 0.5x |
| Cash | US$329.00m |
| Equity | US$6.66b |
| Total liabilities | US$6.85b |
| Total assets | US$13.52b |
Recent financial health updates
Is Bausch + Lomb (NYSE:BLCO) Using Too Much Debt?
Sep 13
Is Bausch + Lomb (NYSE:BLCO) Using Too Much Debt?
Mar 25Recent updates
Bausch + Lomb Corporation (NYSE:BLCO) Shares Fly 25% But Investors Aren't Buying For Growth
Oct 14With Buyout Interest, Bausch + Lomb May Still Be Worth Interest At Current Levels
Sep 19Is Bausch + Lomb (NYSE:BLCO) Using Too Much Debt?
Sep 13Little Excitement Around Bausch + Lomb Corporation's (NYSE:BLCO) Revenues
Jun 22Bausch + Lomb's Bet-The-Farm Xiidra Acquisition Is Looking Questionable, But Miebo Could Make The Stock A Winner
May 24Bausch + Lomb Corporation (NYSE:BLCO) Shares Could Be 32% Below Their Intrinsic Value Estimate
Apr 30Is Bausch + Lomb (NYSE:BLCO) Using Too Much Debt?
Mar 25Many Still Looking Away From Bausch + Lomb Corporation (NYSE:BLCO)
Feb 19Hovering Around 52-Week Low, Bausch + Lomb May Be Poised For A Rebound
Jan 31Bausch + Lomb Corporation's (NYSE:BLCO) Intrinsic Value Is Potentially 34% Above Its Share Price
Jan 14Bausch + Lomb: Not A Good Time To Buy (Rating Downgrade)
Nov 08Why Investors Shouldn't Be Surprised By Bausch + Lomb Corporation's (NYSE:BLCO) Low P/S
Nov 03An Intrinsic Calculation For Bausch + Lomb Corporation (NYSE:BLCO) Suggests It's 46% Undervalued
Aug 15Bausch + Lomb: Growth Should Accelerate As Supply Issues Ease
Aug 09These Return Metrics Don't Make Bausch + Lomb (NYSE:BLCO) Look Too Strong
May 09Bausch + Lomb Corporation (NYSE:BLCO) Shares Could Be 24% Below Their Intrinsic Value Estimate
Mar 28Bausch + Lomb Non-GAAP EPS of $0.23 beats by $0.01, revenue of $996M beats by $32.08M
Feb 22Bausch + Lomb's photodynamic laser gets FDA approval for use with Visudyne
Feb 01Bausch + Lomb: Still A Favorable Risk-To-Reward Prospect
Jan 24Financial Position Analysis
Short Term Liabilities: BLCO's short term assets ($2.8B) exceed its short term liabilities ($1.8B).
Long Term Liabilities: BLCO's short term assets ($2.8B) do not cover its long term liabilities ($5.1B).
Debt to Equity History and Analysis
Debt Level: BLCO's net debt to equity ratio (64.6%) is considered high.
Reducing Debt: Insufficient data to determine if BLCO's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BLCO has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if BLCO has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.